TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
DRUG

Bright Minds Biosciences Inc

Healthcare · Biotechnology

61.00$ -0.9% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Bright Minds Biosciences Inc (DRUG): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/13/2026.

Next report 08/13/2026
Last report 08/14/2026
Earnings surprise by quarter (%)
Q3 24 · 71.7 % 24 Q4 24 · 102.0 % 24 Q1 25 · 25.6 % 25 Q2 25 · 15.9 % 25 Q3 25 · 42.9 % 25 Q4 25 · 17.8 % 25 Q1 26 · 13.5 % 26 Q2 26 · 87.8 % 26

EPS estimate beaten

Full history 8 of 12 quarters (67%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?